834 related articles for article (PubMed ID: 20805679)
21. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators.
Cao C; Yin C; Shou S; Wang J; Yu L; Li X; Chai Y
Shock; 2018 Nov; 50(5):595-605. PubMed ID: 29324628
[TBL] [Abstract][Full Text] [Related]
22. Acanthoic acid ameliorates lipopolysaccharide-induced acute lung injury.
Qiushi W; Guanghua L; Guangquan X
Eur J Pharmacol; 2015 Mar; 750():32-8. PubMed ID: 25620130
[TBL] [Abstract][Full Text] [Related]
23. The total alkaloids of Aconitum tanguticum protect against lipopolysaccharide-induced acute lung injury in rats.
Wu G; Du L; Zhao L; Shang R; Liu D; Jing Q; Liang J; Ren Y
J Ethnopharmacol; 2014 Sep; 155(3):1483-91. PubMed ID: 25102245
[TBL] [Abstract][Full Text] [Related]
24. The protective effect of Trillin LPS-induced acute lung injury by the regulations of inflammation and oxidative state.
Jiang W; Luo F; Lu Q; Liu J; Li P; Wang X; Fu Y; Hao K; Yan T; Ding X
Chem Biol Interact; 2016 Jan; 243():127-34. PubMed ID: 26363199
[TBL] [Abstract][Full Text] [Related]
25. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M
Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237
[TBL] [Abstract][Full Text] [Related]
26. PIM1 inhibitor SMI-4a attenuated lipopolysaccharide-induced acute lung injury through suppressing macrophage inflammatory responses via modulating p65 phosphorylation.
Wang J; Cao Y; Liu Y; Zhang X; Ji F; Li J; Zou Y
Int Immunopharmacol; 2019 Aug; 73():568-574. PubMed ID: 31203114
[TBL] [Abstract][Full Text] [Related]
27. Zingerone attenuates lipopolysaccharide-induced acute lung injury in mice.
Xie X; Sun S; Zhong W; Soromou LW; Zhou X; Wei M; Ren Y; Ding Y
Int Immunopharmacol; 2014 Mar; 19(1):103-9. PubMed ID: 24412620
[TBL] [Abstract][Full Text] [Related]
28. Penehyclidine hydrochloride postconditioning on lipopolysaccharide-induced acute lung injury by inhibition of inflammatory factors in a rodent model.
Wu GM; Mou M; Mo LQ; Liu L; Ren CH; Chen Y; Zhou J
J Surg Res; 2015 May; 195(1):219-27. PubMed ID: 25577143
[TBL] [Abstract][Full Text] [Related]
29. Exogenous ghrelin ameliorates acute lung injury by modulating the nuclear factor κB inhibitor kinase/nuclear factor κB inhibitor/nuclear factor κB pathway after hemorrhagic shock.
Zhang LN; Gong WD; Luo J; Yu YJ; Qi SH; Yue ZY
Int Immunopharmacol; 2019 Apr; 69():95-102. PubMed ID: 30690345
[TBL] [Abstract][Full Text] [Related]
30. Penehyclidine hydrochloride attenuates LPS-induced acute lung injury involvement of NF-kappaB pathway.
Shen W; Gan J; Xu S; Jiang G; Wu H
Pharmacol Res; 2009 Oct; 60(4):296-302. PubMed ID: 19386282
[TBL] [Abstract][Full Text] [Related]
31. Anti-inflammatory effects of novel curcumin analogs in experimental acute lung injury.
Zhang Y; Liang D; Dong L; Ge X; Xu F; Chen W; Dai Y; Li H; Zou P; Yang S; Liang G
Respir Res; 2015 Mar; 16(1):43. PubMed ID: 25889862
[TBL] [Abstract][Full Text] [Related]
32. Citral inhibits lipopolysaccharide-induced acute lung injury by activating PPAR-γ.
Shen Y; Sun Z; Guo X
Eur J Pharmacol; 2015 Jan; 747():45-51. PubMed ID: 25281205
[TBL] [Abstract][Full Text] [Related]
33. Suppression of P2X7/NF-κB pathways by Schisandrin B contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury.
Cai Z; Liu J; Bian H; Cai J; Zhu G
Arch Pharm Res; 2016 Apr; 39(4):499-507. PubMed ID: 26832323
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic effect of methyl salicylate 2-O-β-d-lactoside on LPS-induced acute lung injury by inhibiting TAK1/NF-kappaB phosphorylation and NLRP3 expression.
Yang S; Yu Z; Yuan T; Wang L; Wang X; Yang H; Sun L; Wang Y; Du G
Int Immunopharmacol; 2016 Nov; 40():219-228. PubMed ID: 27620503
[TBL] [Abstract][Full Text] [Related]
35. Molecular hydrogen ameliorates lipopolysaccharide-induced acute lung injury in mice through reducing inflammation and apoptosis.
Xie K; Yu Y; Huang Y; Zheng L; Li J; Chen H; Han H; Hou L; Gong G; Wang G
Shock; 2012 May; 37(5):548-55. PubMed ID: 22508291
[TBL] [Abstract][Full Text] [Related]
36. Penehyclidine prevents nuclear factor-kappaB activation in acute lung injury induced by lipopolysaccharide.
Li J; Li J; Zhang L; Huang Y; Pan JH; Chen KZ
J Pharm Pharmacol; 2008 Sep; 60(9):1197-205. PubMed ID: 18718124
[TBL] [Abstract][Full Text] [Related]
37. Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury.
Chimenti L; Camprubí-Rimblas M; Guillamat-Prats R; Gomez MN; Tijero J; Blanch L; Artigas A
Thromb Haemost; 2017 Nov; 117(11):2125-2134. PubMed ID: 29202212
[No Abstract] [Full Text] [Related]
38. Arctigenin attenuates lipopolysaccharide-induced acute lung injury in rats.
Shi X; Sun H; Zhou D; Xi H; Shan L
Inflammation; 2015 Apr; 38(2):623-31. PubMed ID: 25008149
[TBL] [Abstract][Full Text] [Related]
39. Usnic acid protects LPS-induced acute lung injury in mice through attenuating inflammatory responses and oxidative stress.
Su ZQ; Mo ZZ; Liao JB; Feng XX; Liang YZ; Zhang X; Liu YH; Chen XY; Chen ZW; Su ZR; Lai XP
Int Immunopharmacol; 2014 Oct; 22(2):371-8. PubMed ID: 25068825
[TBL] [Abstract][Full Text] [Related]
40. Effects of alliin on LPS-induced acute lung injury by activating PPARγ.
Wang YL; Guo XY; He W; Chen RJ; Zhuang R
Microb Pathog; 2017 Sep; 110():375-379. PubMed ID: 28711511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
